Molluscum Contagiosum in Emergency Medicine 

  • Author: Peter P Taillac, MD; Chief Editor: Pamela L Dyne, MD   more...
 
Updated: Jul 2, 2008
 

Background

Molluscum contagiosum is a benign viral disease of the skin that is caused by a member of the poxvirus group, molluscum contagiosum virus (MCV). The virus is one of the largest that causes human disease, measuring 240-320 nm in diameter.

Bateman first described the disease in 1817. The term molluscum was used to describe the pedunculated appearance, and the term contagiosum was used to connote that the disease is transmissible.

Interestingly, the idea of an infectious etiology arose after successful transmission occurred in humans who were inoculated with the materials contained within the lesions (see images below). Goodpasture first noted the microscopic similarities that exist between molluscum contagiosum and vaccinia (ie, smallpox).

Typical molluscum lesions on buttocks. Photo courtTypical molluscum lesions on buttocks. Photo courtesy of F. Fehl III, MD. Molluscum lesions on face and neck. Photo courtesyMolluscum lesions on face and neck. Photo courtesy of F. Fehl III, MD.
Next

Pathophysiology

This virus is known to infect only the epidermis. The initial infection seems to occur in the basal layer, and it may be accompanied by a latent period of as long as 6 months. The incubation period is usually shorter (ie, 2-7 wk). This is suggested by the fact that while viral particles are noted in the basal layer, viral DNA replication and the formation of new viral particles do not occur until the spindle and granular layers of the epidermis are involved.

Occasionally, the lesions can progress beyond the local cellular proliferation, and they can become inflamed with the attendant edema, increased vascularity, and infiltration by neutrophils, lymphocytes, and monocytes. Usually, this only occurs if there is a secondary bacterial infection or if rupture into the dermis occurs.

Cell-mediated immunity is thought to be important in modulating and controlling the infection because children and HIV-infected patients are noted to have more widespread and persistent lesions. The incidence and severity of molluscum in HIV-positive and AIDS patients appears to be inversely related to the CD4 count. More severe cases also have been noted in patients who are receiving prednisone and methotrexate. The virus infrequently induces antibody formation; therefore, it is not strongly immunogenic, and reinfection is common.

Previous
Next

Epidemiology

Frequency

United States

Molluscum contagiosum is a common infection throughout the United States. It accounts for approximately 1% of all diagnoses of skin disorders. The exact incidence in the United States is unknown. Higher incidence in children with eczema as well as in immunocompromised individuals has been documented.

The infection is transmitted by close physical contact, fomites, and autoinoculation (whereby the patient manually spreads the infection from one location to another, by touching or scratching). Crowded living conditions, use of public pools, and sharing of clothes and towels by infected persons have all been implicated in the spread of the virus.

International

Molluscum contagiosum has an incidence of up to 4.5% in some population groups. During a regional outbreak in East Africa, it was estimated that 17% of a village's general population and up to 52% of children older than 2 years developed lesions. Poverty, overcrowding, and poor hygiene play key roles in the propagation of this disease. There appears to be a greater incidence of molluscum in tropical areas, although fairly high incidences have been documented in northern European countries as well.

An Australian study found anti-MCV antibodies in 39% of adults older than 50 years, demonstrating exposure to be very common.

Mortality/Morbidity

Molluscum contagiosum is a benign process; therefore, morbidity and mortality are limited.

  • For the most part, morbidity is due to adverse cosmetic results, which usually resolve, without scarring.
  • The lesions can undergo secondary bacterial infection, but morbidity is limited when appropriate antibiotics are used.
  • Morbidity is greater in immunocompromised and immunodeficient patients since they tend to have a greater number of lesions and more widespread infection, resulting in a greater likelihood of superinfection.
  • Despite the rather benign, self-limited course, parents of affected children perceive molluscum to be a significant problem. They cite concerns with scarring, pain, itching, painful treatment, and the chance of spread to peers.

Race

  • There is no well-documented predilection for infection among any racial group.
  • In one longitudinal study in the United States, 2-4 times as many cases occurred among whites than among other racial groups. This study took place from 1977-1981, and it is unclear if the noted difference was secondary to the differences in accessibility to medical care or other socioeconomic factors.

Sex

Studies do not demonstrate any definite difference in incidence between the sexes.

Age

Infection with molluscum contagiosum occurs in all age groups, and prevalence seems to be increasing.

  • The greatest incidence is in children younger than 5 years. This is thought to result from casual contact and autoinoculation.
  • Another smaller spike of incidence occurs in young adults, resulting from propagation through sexual contact.
  • Infection in infants is rare, perhaps because of the persistence of maternal antibodies.
Previous
 
 
Contributor Information and Disclosures
Author

Peter P Taillac, MD  Associate Clinical Professor of Surgery, Division of Emergency Medicine, University of Utah Health Sciences Center

Peter P Taillac, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Eric M Kardon, MD, FACEP  Attending Emergency Physician, Georgia Emergency Medicine Specialists; Physician, Division of Emergency Medicine, Athens Regional Medical Center

Eric M Kardon, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Mark W Fourre, MD  Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD  Professor of Clinical Medicine/Emergency Medicine, University of California, Los Angeles, David Geffen School of Medicine; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

References
  1. Mathes EF, Frieden IJ. Treatment of molluscum contagiosum with cantharidin: a practical approach. Pediatr Ann. Mar 2010;39(3):124-8, 130. [Medline].

  2. Brown M, Paulson C, Henry SL. Treatment for anogenital molluscum contagiosum. Am Fam Physician. Oct 15 2009;80(8):864. [Medline].

  3. Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol. 1996;13(4):310-2. [Medline].

  4. Meadows KP, Tyring SK, Pavia AT. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol. 1997;133(8):987-90. [Medline].

  5. Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled double-blind study. Dermatology. 1994;189(1):65-8. [Medline].

  6. Binder B, Weger W, Komericki P, Kopera D. Treatment of molluscum contagiosum with a pulsed dye laser: Pilot study with 19 children. J Dtsch Dermatol Ges. Feb 2008;6(2):121-5. [Medline].

  7. Braue A, Ross G, Varigos G. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol. Jul-Aug 2005;22(4):287-94. [Medline].

  8. Brown J, Janniger CK, Schwartz RA. Childhood molluscum contagiosum. Int J Dermatol. Feb 2006;45(2):93-9. [Medline].

  9. Coloe J, Burkhart CN, Morrell DS. Molluscum contagiosum: what's new and true?. Pediatr Ann. Jun 2009;38(6):321-5. [Medline].

  10. Dohil MA, Lin P, Lee J. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. Jan 2006;54(1):47-54. [Medline].

  11. Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatolog Treat. 2005;16(5-6):336-40. [Medline].

  12. Luisto M. Unusual and iatrogenic sources of tetanus. Ann Chir Gynaecol. 1993;82(1):25-9. [Medline].

  13. Ordoukhanian E, Lane AT. Warts and molluscum contagiosum: Beware of treatments worse than the disease. Postgrad Med. 1997;101(2):223-35. [Medline].

  14. Peter G, ed. American Academy of Pediatrics, Molluscum Contagiosum. In: Red Book: Report on the Committee on Infectious Diseases. 24th ed. 1997:364.

  15. Scheinfeld NS. Molluscum contagiosum. Skinmed. Mar-Apr 2008;7(2):89-92. [Medline].

Previous
Next
 
Typical molluscum lesions on buttocks. Photo courtesy of F. Fehl III, MD.
Molluscum lesions on face and neck. Photo courtesy of F. Fehl III, MD.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.